Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
FUNDC1 drives cholangiocarcinoma progression via RAC1 interaction and ferroptosis suppression
Xuanming Luo1, Min Li1, Yuda Gong1
1Department of Biliary Surgery, Zhongshan Hospital, Fudan University, Shanghai, China; Department of General Surgery, Shanghai Xuhui Central Hospital, Fudan University, Shanghai, China; Biliary Tract Disease Center of Zhongshan Hospital, Fudan University, China; Cancer Center, Zhongshan Hospital, Fudan University, China; Biliary Tract Disease Institute, Fudan University, China; Shanghai Engineering Research Center of Biliary Tract Minimal Invasive Surgery and Materials, China.
FUNDC1 protein is elevated in cholangiocarcinoma (CCA), promoting cancer progression via ferroptosis. Targeting FUNDC1 and RAC1 may offer new therapeutic strategies for this lethal biliary tract cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cholangiocarcinoma (CCA) is a deadly biliary tract cancer with limited treatment options.
- FUND14 domain-containing protein 1 (FUNDC1) expression is elevated in CCA.
- Mitochondrial dysfunction and ferroptosis are implicated in cancer progression.
Purpose of the Study:
- To investigate the role of FUNDC1 in CCA progression.
- To explore the relationship between FUNDC1, mitochondrial function, and ferroptosis in CCA.
- To identify potential therapeutic targets for CCA.
Main Methods:
- Analysis of FUNDC1 expression in CCA tissues and cell lines.
- Assessment of mitochondrial membrane potential (MMP), reactive oxygen species (ROS), and glutathione (GSH) levels.
- Investigated ferroptosis markers (Gpx4, SLC7A11, NCOA4).
- Studied the interaction between FUNDC1 and RAC1 using immunoprecipitation.
- Evaluated the effect of FUNDC1 and RAC1 knockdown on tumor growth in vivo.
Main Results:
- FUNDC1 expression is significantly higher in CCA than in normal tissues, correlating with poor prognosis.
- FUNDC1 knockdown disrupts mitochondrial membrane potential, increases ROS, and alters ferroptosis markers in CCA cells.
- FUNDC1 interacts with RAC1, and this interaction is crucial for FUNDC1-induced malignant transformation.
- FUNDC1 knockdown induces ferroptosis, while RAC1 knockdown does not, but both reduce tumor volume in vivo.
- FUNDC1 promotes CCA progression via mitochondrial function-dependent ferroptosis.
Conclusions:
- FUNDC1 plays a critical role in promoting CCA progression.
- FUNDC1-induced ferroptosis, mediated by mitochondrial dysfunction and RAC1 interaction, drives CCA malignancy.
- FUNDC1 represents a promising therapeutic target for cholangiocarcinoma treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

